Philip B. Miner

6.1k total citations
135 papers, 4.4k citations indexed

About

Philip B. Miner is a scholar working on Gastroenterology, Surgery and Genetics. According to data from OpenAlex, Philip B. Miner has authored 135 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Gastroenterology, 86 papers in Surgery and 21 papers in Genetics. Recurrent topics in Philip B. Miner's work include Gastroesophageal reflux and treatments (65 papers), Helicobacter pylori-related gastroenterology studies (55 papers) and Gastrointestinal motility and disorders (35 papers). Philip B. Miner is often cited by papers focused on Gastroesophageal reflux and treatments (65 papers), Helicobacter pylori-related gastroenterology studies (55 papers) and Gastrointestinal motility and disorders (35 papers). Philip B. Miner collaborates with scholars based in United States, United Kingdom and Belgium. Philip B. Miner's co-authors include Wendy L. Biddle, Paramjit Bhatia, Mark Sostek, Yusong Chen, Philip O. Katz, N W Read, Allan P. Weston, Mark K. Wedel, Malcolm Robinson and Sheila Rodriguez-Stanley and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Philip B. Miner

129 papers receiving 4.2k citations

Peers

Countries citing papers authored by Philip B. Miner

Since Specialization

Citations

This map shows the geographic impact of Philip B. Miner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip B. Miner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip B. Miner more than expected).

Fields of papers citing papers by Philip B. Miner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip B. Miner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip B. Miner. The network helps show where Philip B. Miner may publish in the future.

Co-authorship network of co-authors of Philip B. Miner

This figure shows the co-authorship network connecting the top 25 collaborators of Philip B. Miner. A scholar is included among the top collaborators of Philip B. Miner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip B. Miner. Philip B. Miner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation 2017 ·The American Journal of Gastroenterology ·Philip B. Miner, William Koltun, Gregory Wiener, (unknown), (unknown), Kunwar Shailubhai, (unknown), Laura Barrow, Leslie Magnus, Patrick Griffin	99
2	Histamine₂-receptor antagonists: Rapid development of tachyphylaxis with repeat dosing 2014 ·World Journal of Gastrointestinal Pharmacology and Therapeutics ·Johnson W. McRorie, (unknown), Philip B. Miner	44
3	Clinical trial: evaluation of gastric acid suppression with three doses of immediate‐release esomeprazole in the fixed‐dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric‐coated esomeprazole 20 mg: a randomized, open‐label, Phase I study in healthy volunteers 2010 ·Alimentary Pharmacology & Therapeutics ·Philip B. Miner, John R. Plachetka, (unknown), John G. Fort, Mark Sostek	18
4	Intragastric acid control in non‐steroidal anti‐inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole 2006 ·Alimentary Pharmacology & Therapeutics ·Jay L. Goldstein, Philip B. Miner, Paul K. Schlesinger, (unknown), Debra G. Silberg	21
5	Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment 2006 ·Alimentary Pharmacology & Therapeutics ·Philip B. Miner, (unknown), Julie Grender	44
6	Esophageal Visceral Sensitivity to Bile Salts in Patients with Functional Heartburn and in Healthy Control Subjects 2005 ·Digestive Diseases and Sciences ·Ali Siddiqui, Sheila Rodriguez-Stanley, (unknown), Philip B. Miner	60
7	Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro‐oesophageal reflux disease 2005 ·Alimentary Pharmacology & Therapeutics ·David C. Metz, Philip B. Miner, Douglas M. Heuman, (unknown), Mark Sostek	8
8	Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux Disease 2005 ·Digestive Diseases and Sciences ·Peter J. Kahrilas, Philip B. Miner, John F. Johanson, Lian Mao, Leonard Jokubaitis, Sheldon Sloan	37
9	The fractal nature of human gastro‐oesophageal reflux 2005 ·Alimentary Pharmacology & Therapeutics ·Jerry D. Gardner, (unknown), (unknown), Malcolm Robinson, Philip B. Miner	6
10	Review article: relief of symptoms in gastric acid‐related diseases – correlation with acid suppression in rabeprazole treatment 2004 ·Alimentary Pharmacology & Therapeutics ·Philip B. Miner	15
11	Neurotrophin-3 Improves Functional Constipation 2003 ·The American Journal of Gastroenterology ·Henry P. Parkman, Satish S.C. Rao, James C. Reynolds, Lawrence R. Schiller, Arnold Wald, Philip B. Miner, Anthony Lembo, James M. Gordon, Douglas A. Drossman, (unknown), Nancy Stambler, Jesse M. Cedarbaum	59
12	Effects of antacid formulation on postprandial oesophageal acidity in patients with a history of episodic heartburn 2002 ·Alimentary Pharmacology & Therapeutics ·Malcolm Robinson, (unknown), Philip B. Miner, Alistair McGuire, (unknown), A. A. Ciociola	16
13	Control of Nocturnal Gastric Acidity: A Role for Low Dose Bedtime Ranitidine to Supplement Daily Omeprazole 2002 ·Digestive Diseases and Sciences ·Malcolm Robinson, Sheila Rodriguez-Stanley, Arthur A. Ciociola, (unknown), (unknown), Philip B. Miner, Jerry D. Gardner	11
14	Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease 1999 ·Gastroenterology ·Bruce E. Sands, (unknown), Charles A. Sninsky, (unknown), Seymour Katz, John W. Singleton, Philip B. Miner, Michael Safdi, Susan Galandiuk, Stephen B. Hanauer, Gary W. Varilek, Alan L. Buchman, Vance D. Rodgers, Bruce Salzberg, Bin Cai, John W. Loewy, (unknown), (unknown), Mark Shapiro, Ullrich Schwertschlag	146
15	Esophageal Hypersensitivity May Be A Major Cause of Heartburn 1999 ·The American Journal of Gastroenterology ·Sheila Rodriguez-Stanley, (unknown), (unknown), Beverley Greenwood–Van Meerveld, Philip B. Miner	93
16	New therapeutic agents in the treatment of inflammatory bowel disease 1992 ·The American Journal of Medicine ·(unknown), Philip B. Miner	26
17	Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis 1992 ·Digestive Diseases and Sciences ·(unknown), (unknown), Paramjit Bhatia, Julie Moore, Philip B. Miner	78
18	Relation between rectal sensation and anal function in normal subjects and patients with faecal incontinence. 1990 ·Gut ·Weiming Sun, N W Read, Philip B. Miner	100
19	Gastric mucosal nodules due to cytomegalovirus infection 1989 ·Digestive Diseases and Sciences ·(unknown), Glendon G. Cox, Paramjit Bhatia, Philip B. Miner	17
20	5-Aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis 1988 ·Gastroenterology ·Wendy L. Biddle, Norton J. Greenberger, (unknown), Mark S. McPhee, Philip B. Miner	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact